Invesco BulletShares 2029 Corporate Bond (BSCT)
BSCT price chart
BSCT fund facts
Returns and risk
Cost: expense ratio
On $10,000 invested that is about $10 a year in fund costs, taken out of the fund's assets.
Income: distributions
BSCT top holdings
| # | Holding | Weight |
|---|---|---|
| 1 | Invesco Private Prime Fund | 6.88% |
| 2 | Invesco Private Government Fund | 2.65% |
| 3 | AbbVie Inc. | 1.27% |
| 4 | Salesforce, Inc. | 1.04% |
| 5 | International Business Machines Corp. | 0.77% |
| 6 | Centene Corp. | 0.77% |
| 7 | Verizon Communications Inc. | 0.73% |
| 8 | AT&T Inc. | 0.73% |
| 9 | Amazon.com, Inc. | 0.73% |
| 10 | Oracle Corp. | 0.72% |
Similar Bond ETFs
IBMR iShares iBonds Dec 2029 Term M...0.18% fee · +1.0% 1y IBTH iShares iBonds Dec 2027 Term T...0.07% fee · +2.8% 1y IBMQ iShares iBonds Dec 2028 Term M...0.18% fee · +1.8% 1y XHLF BondBloxx Bloomberg Six Month...0.03% fee · +3.5% 1y IBDW iShares iBonds Dec 2031 Term C...0.10% fee · −0.4% 1y XTEN BondBloxx Bloomberg Ten Year T...0.08% fee · −3.8% 1y All bond ETFs →BSCT: frequently asked questions
What is BSCT?
BSCT is the Invesco BulletShares 2029 Corporate Bond ETF, issued by Invesco, listed on NASDAQ. By our rules it is classed as "Bond". Its latest SEC filing lists 457 holdings.
What is the expense ratio of BSCT?
BSCT charges 0.10% a year, according to its prospectus filed with the SEC on 18 Dec 2025. On $10,000 that is about $10 a year in fund costs.
Does BSCT pay dividends?
Yes. BSCT paid 0.84 per share over the last 12 months, monthly, a trailing yield of 4.57% on today's price. The latest ex-dividend date was 19 Oct 2026.
What does BSCT hold?
The largest holdings in the latest SEC filing are Invesco Private Prime Fund (6.9%), Invesco Private Government Fund (2.6%), AbbVie Inc. (1.3%). The top 10 together make up 16.3% of the fund.
How has BSCT performed?
Total return including distributions to 22 Oct 2026: 1 year +1.4%, 3 years +6.7% a year, 5 years +1.3% a year. Past performance does not guarantee future results.
Where the numbers come from
StocksXray is for education only and is not financial advice or a recommendation to buy or sell anything. Past performance does not guarantee future results; funds can lose value.